12
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Tricyclic Antidepressant-Specific fab fragments alter the distribution and elimination of desipramine in the rabbit: A Model for overdose treatment

, , , &
Pages 53-66 | Published online: 25 Sep 2008

References

  • Frommer D. A., Kulig K. W., Marx J. A., Rumack B. Tricyclic antidepressant overdose: a review. JAMA. 1987; 257: 521–526
  • Wenger T. L., Butler V. P., Haber E., Smith T. W. Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments. J. Am. Coll. Cardiol. 1985; 5: 118A–123A, (supplement 5)
  • Butler V. P., Schmidt D. H., Smith T. W., Haber E., Raynor B. D., DeMartini P. Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs. J. Clin. Invest. 1977; 59: 345–359
  • Owens S. M., Mayersohn M. Phencyclidine-specific Fab fragments alter phencyclidine disposition in dogs. Drug. Metab. Dispo. 1986; 14: 52–58
  • Pentel P. R., Pond S. M., Schoof D. D. Redistribution into plasma of tracer doses of 3H-desipramine by anti-desipramine antiserum in rats. Biochem. Pharmacol. 1987; 36: 293–295
  • Coulter A., Harris R. Simplified preparation of rabbit Fab fragments. J. Immunol. Methods. 1983; 59: 199–203
  • Wolfer G. K., Jr., Rippon W. B. Protocols for the use of ultrafiltration in determination of free ligand concentration and of complexity of ligand/protein interactions. Clin. Chem. 1987; 33: 115–117
  • Liu D., Purssell R., Levy J. G. Production and characterization of high affinity monoclonal antibodies to cyclic anti-depressant molecules. Clin. Toxicol. 1987; 25: 527–538

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.